Cargando…

Who Treats Patients with Diabetes and Compensated Cirrhosis

BACKGROUND: Increasingly, patients with multiple chronic conditions are being managed in patient-centered medical homes (PCMH) that coordinate primary and specialty care. However, little is known about the types of providers treating complex patients with diabetes and compensated cirrhosis. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tsai-Ling, Barritt IV, A. Sidney, Weinberger, Morris, Paul, John E., Fried, Bruce, Trogdon, Justin G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082637/ https://www.ncbi.nlm.nih.gov/pubmed/27783702 http://dx.doi.org/10.1371/journal.pone.0165574

Ejemplares similares

Correction: Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2018)

In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge
por: Moon, Andrew M., et al.
Publicado: (2020)

Nationally Representative Medical Costs of Diabetes by Time Since Diagnosis
por: Trogdon, Justin G., et al.
Publicado: (2008)

Liver stiffness and thrombin generation in compensated cirrhosis
por: Dillon, Audrey, et al.
Publicado: (2019)

Liver Transplant for Unusually Large Polycystic Liver Disease: Challenges and Pitfalls
por: Serrano Rodriguez, Pablo, et al.
Publicado: (2018)

Evaluating the association of social needs assessment data with cardiometabolic health status in a federally qualified community health center patient population
por: Drake, Connor, et al.
Publicado: (2021)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Small Bowel Abnormalities in Patients with Compensated Liver Cirrhosis
por: Aoyama, Taiki, et al.
Publicado: (2012)

Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis
por: Bloom, P.P., et al.
Publicado: (2022)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 1: compensated cirrhosis
por: Mansour, Dina, et al.
Publicado: (2023)

Frequency of minimal hepatic encepalopathy in illeterate patients with compensated cirrhosis
por: Zuberi, Bader Faiyaz, et al.
Publicado: (2016)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Compensated liver cirrhosis: Natural course and disease-modifying strategies
por: Kumar, Ramesh, et al.
Publicado: (2023)

Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know
por: Barritt, A. Sidney, et al.
Publicado: (2022)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis
por: John, Binu V., et al.
Publicado: (2022)

The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis
por: Chang, Ya-Chun, et al.
Publicado: (2022)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
por: Tangjarusritaratorn, Thanida, et al.
Publicado: (2021)

Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective Study
por: Su, Pei-Yuan, et al.
Publicado: (2021)

Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control Study
por: Buscail, Camille, et al.
Publicado: (2018)

Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis
por: Balakrishnan, Maya, et al.
Publicado: (2021)

Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
por: Thanapirom, Kessarin, et al.
Publicado: (2021)

The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis
por: Reiberger, Thomas
Publicado: (2021)

Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis
por: McGill, Mitchell R., et al.
Publicado: (2021)

Pregnancy Is Not Associated with an Increased Risk of Decompensation, Transplant, or Death in Compensated Cirrhosis
por: Mullin, Monica, et al.
Publicado: (2022)

Can Medicaid be a Solution to the Problem? Underinsurance in Medicaid Expansion Versus Non-Expansion States
por: Izguttinov, Aniyar, et al.
Publicado: (2023)

Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS
por: John, Binu V., et al.
Publicado: (2022)

Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
por: Mihai, Florin, et al.
Publicado: (2020)

Circulating granulocyte lifespan in compensated alcohol‐related cirrhosis: a pilot study
por: Potts, Jonathan R., et al.
Publicado: (2016)

In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis
por: Lisman, Ton, et al.
Publicado: (2018)

Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis
por: Horvath, Angela, et al.
Publicado: (2020)

Autologous bone marrow cell transplantation in the treatment of HIV patients with compensated cirrhosis
por: Liu, Baochi, et al.
Publicado: (2020)

Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
por: Surana, Pallavi, et al.
Publicado: (2021)

A case report of a pregnant woman with compensated liver cirrhosis and pancytopenia
por: S. S, Sreenisha, et al.
Publicado: (2023)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Testing the organizational theory of innovation implementation effectiveness in a community pharmacy medication management program: a hurdle regression analysis
por: Turner, Kea, et al.
Publicado: (2018)

Increased sinusoidal export of drug glucuronides is a compensative mechanism in liver cirrhosis of mice
por: Fendt, Rebekka, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard
por: Moon, Andrew M., et al.
Publicado: (2020)

Arterial Blood Pressure Is Closely Related to Ascites Development in Compensated HCV-Related Cirrhosis
por: Vilar Gomez, Eduardo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_54hlb2gu5cn0a1mc18sq8pgv5k